Workshop Plantas Medicinais e Fitoterapêuticas nos Trópicos. IICT /CCCM, 29, 30 e 31 de Outubro de 2008 Antimalarial activity of some plants traditionally used in Mozambique _______________________________________________________________________________________________________ ANTIMALARIAL ACTIVITY OF SOME PLANTS TRADITIONALLY USED IN MOZAMBIQUE Cátia Ramalhete*, Dinora L
Suomen sivusto, jossa voit ostaa halvalla ja laadukas Viagra http://osta-apteekki.com/ toimitus kaikkialle maailmaan.
Erityisesti laatu viagra tästä kaupasta voi taata henkilökohtaisesti kamagra Paras laatu kehotan Teitä miellyttää.
Microsoft word - cv andrea allen 2011 08 30.docAndrea Allen Ph.D.
B.A., 1971, Washington Square College, New York University Ph.D., 1976, Psychology (Social & Personality), Stanford University
PSYCHOLOGY POSITIONS (New York State Licensed Psychologist, #012971)
Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, New York Assistant Clinical Professor of Psychology in Psychiatry, July 2009 to present Director of Psychological Services, Compulsive & Impulsive Disorders Center of Excellence, February 2008 through June 2009 Assistant Professor of Psychology in Psychiatry, August 1998 to June 2009 Research Analyst, Consultant, July 1996 through July 1998 Bronx Lebanon Hospital Center, Grand Concourse Clinic, Bronx, New York Psychologist, part time, July 1995 through December 1997 New York University, School of Continuing Education, New York, New York Adjunct Assistant Professor, Spring & Fall 1990 University of Virginia, Charlottesville, Virginia Assistant Professor of Psychology, September 1975 through June 1979 Stanford University, Stanford, California Visiting Assistant Professor of Psychology, Summer 1976 CLINICAL PSYCHOLOGY TRAINING
University of Medicine & Dentistry of New Jersey, University Behavioral HealthCare Newark, New Jersey, Psychology Intern, July 1997 through June 1998 Fairleigh Dickinson University, Psychology Department, Teaneck, New Jersey Clinical Psychology Respecialization, 1993-1998 Mount Sinai School of Medicine, Clinical Neurosciences Program, New York, New York Psychology Extern, July 1995 to June 1996 Bronx Lebanon Hospital Center, Grand Concourse Clinic, Bronx, New York (Formerly the Bronx Center for Community Services) Psychology Extern July 1994 to June 1995 FDU Center for Psychological Services, Hackensack, New Jersey Psychology Fellow, September 1993 to May 1994 BIBLIOGRAPHY
Peer-Reviewed Original Research Publications
Bem DJ, & Allen A. (1974). On predicting some of the people some of the time: The search
for cross-situational consistencies in behavior. Psychological Review, 81, 506-520. Tobiasen JM, & Allen A. (1983). Influence of gaze and physical closeness: A delayed effect.
Perceptual and Motor Skills, 57, 491-495. Aronowitz B, DeCaria C, Allen A, Weiss N, Saunders A, Margolin L, Mosovich S.,
Buchsbaum M, Hollander E. (1997). The neuropsychiatry of Autism and Asperger’s disorder: review of the literature and case reports. CNS Spectrums: International Journal of Neuropsychiatric Medicine, 2, 43-60. Hollander E, Allen A, Kwon J, Aronowitz BR, Schmeidler J, Wong C, Simeon S. (1999).
Clomipramine vs. desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Archives of General Psychiatry, 56:1033-1039. Hollander E, Novotny S, Allen A, Aronowitz B, Cartwright C, DeCaria C. (2000). The
relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology. 22:163-7. Novotny S, Hollander E, Allen A, Mosovich S, Aronowitz BR, Cartwright C, DeCaria C.
(2000). Increased growth hormone response to sumatriptan challenge in adult autistic disorders. Psychiatry Research,. 94:173-7. Hollander E, Allen A, Prieto Lopez R, Bienstock C, Grossman R, Siever L, Margolin L, Stein
D. (2001) A Preliminary Double Blind Placebo Controlled Trial of Divalproex Sodium in Borderline Personality Disorder. Journal of Clinical Psychiatry, 62:199-203. Hollander E, Allen A, Steiner M, Wheadon DE, Oakes R, Burnham D. (2003) Acute and
long-term treatment and prevention of relapse of obsessive compulsive disorder with paroxetine. Journal of Clinical Psychiatry, 61:1113-1121. Hollander E, Friedberg J, Wasserman S, Allen A, Birnbaum M, Koran LM. (2003)
Venlafaxine in treatment-resistant obsessive-compulsive disorder. Journal of Clinical Psychiatry, 64:546-550. Novotny S, Hollander E, Phillips A, Allen A, Wasserman S, Iyengar R. (2004) Increased
repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders. International Journal of Neuropsychopharmacology, Sep;7(3):249-54. Epub 2004 May 7. Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N. (2005) Does sustained-release lithium
reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? American Journal of Psychiatry, Jan;162(1):137-45. Allen A, Hadley SJ, Kaplan A, Simeon D, Friedberg J, Priday L, Baker BR, Greenberg JL,
Hollander E. (2008) An open-label trial of venlafaxine in body dysmorphic disorder. CNS Spectrums, 13(2):138-44. Dell'Osso B, Hadley S, Allen A, Baker B, Chaplin WF, Hollander E. (2008) Escitalopram in the
treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. Journal of Clinical Psychiatry, Mar;69(3):452-6.
Pallanti S, Bernardi S, Allen A, Chaplin W, Watner D, Decaria C, Hollander E. (2010)
Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine. J Psychopharmacol, 24:847-53. [Epub 2008 Nov 21] Published Review Articles, Chapters, Abstracts, Presentations, Misc.
Allen A. (1976). The role of nonverbal cues in the formation and maintenance of personality
impressions. Dissertation, Stanford University. Allen A. (1978). Persons and situations. Science, 199, 872-873. (Book Review)
Aronowitz BR, DeCaria CM, Allen A, Margolin L, Simon L, Saunders A, Weiss N, Reimoser
GE, Mosovich S, Hollander E. (1997). Neuropsychological findings in Autism, Asperger’s Disorder, Obsessive-Compulsive Disorder and controls. Abstracts of the American Psychiatric Association 150th Annual Meeting, May 22, San Diego, California. Aronowitz BR, Simeon D, Margolin L, Silver L, Cooper B, Margolies S, Swiller H, Schmeidler J, Allen A, Persaud A, Greer J, Hollander E. (1997). A survey of body
dysmorphic disorder in plastic surgery outpatients. Abstracts for the Mount Sinai
Medical Center, Psychiatry Department, Annual Research Day.
Hollander E, Margolin L, Wong C, Grossman R, Siever L, Allen A, Cartwright C. (1998).
Double-blind placebo controlled trial of divalproex sodium in the treatment of borderline personality disorder. Abstracts for the 38th Annual Meeting of NCDEU. Hollander E, Allen A, Schmeidler J, Kwon J, Aronowitz B, DeCaria C. (1998). Clomipramine
vs. desipramine in body dysmorphic disorder: double blind crossover trial. Scientific Abstracts of the 37th Annual Meeting of the American College of Neuropsychopharmacology, Pg. 137. DeCaria C, Hollander E, Margolin L, Grossman R, Seiver L, Allen A, Cartwright C,
Novotny S. (1998). Double-blind placebo controlled trial of Valproate in the treatment of borderline personality disorder: interim analysis. Scientific Abstracts of the 37th Annual Meeting of the American College of Neuropsychopharmacology, Pg. 254. Allen A. (1998). Evaluation of changes in the University Behavioral HealthCare MICA day
treatment program. Abstracts for the University of Medicine & Dentistry of New Jersey, New Jersey Medical School, Department of Psychiatry, Annual Research Day. Allen A, Hollander E, Steiner M, Wheadon DE, Bushnell W, Gergel IP. (1999). Long-term
treatment and prevention of relapse obsessive-compulsive disorder with paroxetine.
Scientific Abstracts of the 38th Annual Meeting of the American College of
Allen A, (1999) Kaplan A. Workshop: Cognitive, Behavioral & Medication Therapies of
Body Dysmorphic Disorder. Obsessive Compulsive Spectrum Disorders Conference, Mt. Sinai School of Medicine, New York, New York. April. Allen A, Hollander E, & Buchsbaum M. (2000). Imaging in Body Dysmorphic Disorder. Abstracts for
the 4th International Obsessive-Compulsive Disorder Conference, February10-12, St Thomas. Hollander E & Allen A. (2000). Quality of Life in OCD. Abstracts for the 4th International
Obsessive-Compulsive Disorder Conference, February 10-12, St Thomas. Allen A & Hollander E. (2000). Body Dysmorphic Disorder. Psychiatric Clinics of North
Allen A. (2000) Body Dysmorphic Disorder. Anxiety Spectrum Disorders: New Concepts
and Effective Treatments Symposium at the Mt. Sinai School of Medicine, New York, New York, November 4. Hollander E, Kaplan A, Allen A, Cartwright C. (2000). Pharmacotherapy for obsessive-
compulsive disorder. Psychiatric Clinics of North America, 23:643-656. Hollander E & Allen A, Editors. (2000). Obsessive-Compulsive Spectrum Disorders.
Psychiatric Clinics of North America, 23. Hollander E, & Allen A. (2001). Serotonergic drugs and the treatment of disorders related to
obsessive-compulsive disorder. In: Pato MT & Zohar J (eds.) Current Treatments of Obsessive-Compulsive Disorder, 2nd Edition. Washington, DC, American Psychiatric Publishing, Inc. Hollander E & Allen A. (2000). Quality of Life in OCD. Abstracts for the 4th International
Obsessive-Compulsive Disorder Conference, February 10-12, St. Thomas. Stein DJ, Allen A, Bobes J, Eisen JL, Figuera ML, Iikura Y, Koran LM, Hollander E. (2000)
Quality of life in Obsessive-Compulsive disorder. CNS Spectrums, 5(6, suppl 4): 37-39. Allen A, King AF, Hollander E. (2003) Obsessive-compulsive spectrum. Dialogues in Clinical
Allen A. (2003) Body Dysmorphic Disorder: Imagined Ugliness. Workshop at Image, Body
& Self Conference, Hofstra University, April 8. Allen A, Hadley SJ, Kaplan A, Simeon D, Friedberg J, Priday L, Greenberg J, Hollander E.
(2003). An open label trial of venlafaxine in body dysmorphic disorder. Poster presented at the 6th International Obsessive-Compulsive Disorder Conference, November 14, Lanzarote, Spain. Allen A, Hollander E. (2004) Psychopharmacological treatment of body image disorders. In
T Cash and T Pruzinski Eds. Body Image: A Handbook of Theory, Research, and Clinical Practice. New York, Guilford Press, pp.450-457. Allen A, Hollander E. (2004) Similarities and differences between body dysmorphic disorder
and other disorders. Psychiatric Annals, 34(4). Dell'Osso B, Altamura AC, Allen A, Hollander E.(2005) Brain stimulation techniques in the
treatment of obsessive-compulsive disorder: current and future directions. CNS Spectrums, Dec;10(12):966-79, 983. Allen A, Hollander E. (2005) Diagnosis and treatment of obsessive-compulsive disorder. Primary Dell'Osso B, Allen A, Hollander E. (2005) Fluvoxamine: a selective serotonin re-uptake inhibitor
for the treatment of obsessive-compulsive disorder. Expert Opinion on Pharmacotherapy, Dec;6(15):2727-40. Dell'Osso B, Allen A, Hollander E. (2005) Comorbidity issues in the pharmacological treatment of
Pathological Gambling: a critical review. Clinical Practice and Epidemiology in Mental Health, Oct 10;1:21. Dell'Osso B, Nestadt G, Allen A, Hollander E. (2006) Serotonin-norepinephrine reuptake
inhibitors in the treatment of obsessive-compulsive disorder: A critical review. Journal of Clinical Psychiatry, 67(4):600-10. Allen A. (2006) Cognitive-behavior therapy and other psychosocial interventions in the
treatment of obsessive compulsive disorder. Psychiatric Annals, 36(7): 474-47 Allen A. (2006) Cognitive-behavioral treatment of body dysmorphic disorder. Primary
Allen A. (2006) Workshop: Cognitive Behavioral Treatment for Body Dysmorphic Disorder.
Presentation at the 2nd Annual Body Dysmorphic Disorder Conference, Hofstra University, Garden City, New York, October 22. Hollander E, Allen A. Beauty is in the eye of the beholder: (2006) New insights in imagined
Ugliness. Guest Editors’ Note. Primary Psychiatry, 13(7): 70-76. Wainberg ML, Muench F, Morgenstern J, Hollander E, Irwin TW, Parsons JT, Allen A,
O'Leary A (2006). A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. Journal of Clinical Psychiatry, 67(12):1968-73. Hollander E, Allen A. (2006) Is compulsive buying a real disorder, and is it really compulsive?
American Journal of Psychiatry, 163(10):1670-2. Dell'Osso B, Altamura AC, Allen A, Marazziti D, Hollander E. (2006) Epidemiologic and
clinical updates on impulse control disorders: a critical review. European Archives of Psychiatry and Clinical Neuroscience, 256(8):464-75. Epub 2006 Sep 7. Allen A, Dell'Osso B, Fochtmann LJ, McIntyre JS. (2007) CME Course for: Practice Guideline
for the Treatment of Patients with Obsessive-Compulsive Disorder. American Psychiatric Association, http://archive.psych.org/cme/apacme/ Dell’Osso B, Allen A, Altamura AC, Buoli M, Hollander E. (2008) Impulsive-compulsive
buying disorder: clinical overview. Australian and New Zealand Journal of Psychiatry, 42:259-266 Sussman, N. (2008) Interview of Andrea Allen: Profiles in Psychiatry: In session with Andrea
Allen PhD: Cognitive behavioral therapy for obsessive-compulsive disorder. Primary Psychiatry, 2008, 15:39-42. Allen A. (2008) Body Dysmorphic Disorder: Imagined Ugliness. Presentation at Fondazione
IRCCS Cà Granda, Ospedale Maggiore Policlinico of Milano, Italy, April 7. Allen A, Hollander E. (2010) Compulsive Sexual Behavior. In Koob GF, Le Moal M, and
Thompson RF (ed). Encyclopedia of Behavioral Neuroscience. Elsevier. Chapter 177, 94-99. Allen A., Pallanti S. (2011) The family in the treatment of obsessive-compulsive disorder. In
Hudak, Robert; and Dougherty, Darin. Clinical Obsessive-Compulsive Disorders in Adults and Children. Cambridge University Press, pp 172-183. Cambridge Books Online. Cambridge University Press. 03 July 2011 PROFESSIONAL AFFILIATIONS
American Psychological Association Association for Psychological Science New York Psychological Association Anxiety Disorders Association of America Association for Behavioral and Cognitive Therapies NYC - CBT Obsessive Compulsive Foundation, professional member & member of the Genetics Society for Personality and Social Psychology (APA Division 8) Society for the Exploration of Psychotherapy Integration
C A S E S T U D Y Cerebellar Atrophy by Karen Shuler, PT, DPT, Lifestyle Physical Therapy, Lake Wylie, SC INTRODUCTION OBJECTIVE DATA AT INITIAL EVALUATION Patient is a 65 y.o. female with a long history of seizures and declining balance over the past 3 years. Her MRI revealed cerebel ar atrophy due to prolonged use of seizure medication. The patient has fal en once over the past